Centre Hospitalier Universitaire de Besancon Clinical Trials
Sponsors / Centre Hospitalier Universitaire de Besancon
402 ClinicalTrials.gov entries name Centre Hospitalier Universitaire de Besancon as the lead sponsor. The portfolio currently includes 42 recruiting studies, 3 active non-recruiting studies, and 172 completed studies. 30 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, business or strategic decisions. Cumulative planned enrollment across all listed trials is 772,700 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
402
Total Trials
42
Recruiting
3
Other Active
172
Completed
30
Terminated / Withdrawn
772,700
Total Enrollment
Termination reasons: Other60% · Recruitment37% · Business3%
Recent Terminations
- Metastatic Colorectal Cancer"enrollment too slow"
- Gallstone"recruitment difficulties"
- Children, Only"recruitement diffculties"
- Mandibular Dysfunction"recruitment difficulties"
- Metastatic Pancreatic Adenocarcinoma"sponsor decision"
- NCT03934749 Stopped Sep 2020Chronic Obstructive Pulmonary Disease"Difficulty of inclusion"
- NCT03468101 Stopped Sep 2020COPD"COVID-19"
- NCT03262194 Stopped Jun 2019Cytomegalovirus Infections"The introduction of new recommendations for early neonatal infection has drastically reduced the need for gastric aspiration at birth."
- Central Serous Chorioretinopathy
- NCT02861404 Stopped Jun 2016Plantar Warts
Active Trials (3 total)
- NCT07469540
- NCT06706349
- NCT07036380
- Hepatocellular Carcinoma PHASE2NCT05528952
- NCT06948565
- NCT06864065
- NCT06337500
- NCT04817072
- NCT06259890
- NCT06805097
- NCT06626269
- NCT05974358
- NCT02839291
- NCT03117946
- NCT04767568
- NCT06397846
- Metastatic Colorectal Cancer PHASE2/PHASE3NCT05462613
- Metastatic Colorectal Cancer PHASE2NCT06425133
- NCT04191395
- Depression NANCT06098469